Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Epizyme: A Promising Long-Term Pick For The Healthcare Investor [Seeking Alpha]

Epizyme, Inc. (EPZM) 
Last epizyme, inc. earnings: 2/24 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: epizyme.com
Company Research Source: Seeking Alpha
Epizyme: A Promising Long-Term Pick For The Healthcare Investor Summary FDA's approval of Tazemetostat would be a significant advance in the field of epigenetics. Label expansion of Tazemetostat may open up significant revenue opportunities. Epizyme can prove to be a promising acquisition target. There are company-specific risks to be considered prior to investing in Epizyme. I had last recommended Epizyme ( EPZM promising pick In this backdrop, I will be explaining why I believe there is still a huge upside potential for the long-term investor in this epigenetics focused stock. FDA approval of Tazemetostat will ensure a significant first-mover advantage to Epizyme in the upcoming field of Epigenetics Today, Cancer epigenetics Epizyme is focused on the epigenetic mechanism of histone modification and is developing therapeutics that can inhibit certain aberrant histone methylation patterns. This is expected to reduce tumor cell proliferation. Tazemetostat inhibits wild-type and mutated Show less Read more
Impact Snapshot
Event Time:
EPZM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for EPZM alerts
Opt-in for
EPZM alerts

from News Quantified
Opt-in for
EPZM alerts

from News Quantified